Invention Grant
- Patent Title: Aryl substituted imidazonaphthyridines
- Patent Title (中): 芳基取代的咪唑并萘啶
-
Application No.: US11570703Application Date: 2005-06-17
-
Publication No.: US07897609B2Publication Date: 2011-03-01
- Inventor: Shri Niwas , Bryon A. Merrill , Philip D. Heppner , Tushar A. Kshirsagar , Gregory D. Lundquist, Jr. , David T. Amos , Kyle J. Lindstrom
- Applicant: Shri Niwas , Bryon A. Merrill , Philip D. Heppner , Tushar A. Kshirsagar , Gregory D. Lundquist, Jr. , David T. Amos , Kyle J. Lindstrom
- Applicant Address: US MN St. Paul
- Assignee: 3M Innovative Properties Company
- Current Assignee: 3M Innovative Properties Company
- Current Assignee Address: US MN St. Paul
- Agency: Wolf, Greenfield & Sacks, P.C.
- Agent C. Hunter Baker
- International Application: PCT/US2005/021436 WO 20050617
- International Announcement: WO2006/038923 WO 20060413
- Main IPC: C07D215/38
- IPC: C07D215/38 ; A61K31/02
Abstract:
Imidazonaphthyridine ring systems substituted with an aryl substituent, pharmaceutical compositions containing the compounds, and methods of use of these compounds as immunomodulators, for inducing cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases are disclosed.
Public/Granted literature
- US20070219228A1 Aryl substituted imidazonaphthyridines Public/Granted day:2007-09-20
Information query
